ERBB2 and neoplasm: Since HER2.CARTs infiltrated both tumor sites in the absence of CAdTrio pre-treatment as well (Fig. 5b), left tumors also expressed pro-inflammatory genes in the HER2.CART only condition (Fig. 5d).